SEPARATION AGREEMENTSeparation Agreement • March 15th, 2017 • Mirna Therapeutics, Inc. • Pharmaceutical preparations • Texas
Contract Type FiledMarch 15th, 2017 Company Industry JurisdictionThis Separation Agreement (the “Agreement”) by and between Jon Irvin (“Executive”) and Mirna Therapeutics, Inc., a Delaware corporation (the “Company”), is made effective eight (8) days after Executive’s signature hereto (the “Effective Date”), unless Executive revokes his acceptance of this Agreement as provided in Section 5(c) below, with reference to the following facts:
MIRNA THERAPEUTICS LETTERHEAD]Employment Agreement • March 15th, 2017 • Mirna Therapeutics, Inc. • Pharmaceutical preparations
Contract Type FiledMarch 15th, 2017 Company IndustryOn behalf of Mirna Therapeutics, Inc. (“Mirna"), a Delaware corporation, I am pleased to offer you the full-time position of Chief Medical Officer. We anticipate your start date to be April 25, 2016 (the “Start Date”).
MIRNA THERAPEUTICS LETTERHEAD]Employment Agreement • March 15th, 2017 • Mirna Therapeutics, Inc. • Pharmaceutical preparations • Texas
Contract Type FiledMarch 15th, 2017 Company Industry JurisdictionThis EMPLOYMENT AGREEMENT (the “Agreement”) is made and entered into this 25th day of April, 2016 (the “Effective Date”) by and between Mirna Therapeutics, Inc., a Delaware corporation (the “Company”) and Vincent J. O’Neill, M.D. (“Employee”).